Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes

Molecular and Cellular Biology

Volumn 24, Issue 24, 2004, Pages 10584-10592

  Sonnenblick, Amir ^a   Levy, Carmit ^a   Razin, Ehud ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; GLYCOPROTEIN GP 130 RECEPTOR; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PIAS3 PROTEIN; PROTEIN; RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN 3T3; CELL STRAIN NIH 3T3; GENE EXPRESSION REGULATION; GROWTH REGULATION; MAST CELL; MELANOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; ZIP DOMAIN;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT DYES; GLUTATHIONE TRANSFERASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, CYTOKINE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINES; RNA, MESSENGER; SERINE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 10044251281     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.24.10584-10592.2004     Document Type: Article

References (47)

1. Bowman, T., M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 98:7319-7324.
2. Bowman, T., R. Garcia, J. Turkson, and R. Jove. 2000. STATs in oncogenesis. Oncogene 19:2474-2488.
3. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295-303.
4. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
5. Dorvault, C. C., K. N. Weilbaecher, H. Yee, D. E. Fisher, L. A. Chiriboga, Y. Xu, and D. C. Chhieng. 2001. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens. Cancer 93:337-343.
6. Duval, D., G. Duval, C. Kedinger, O. Poch, and H. Boeuf. 2003. The "PINIT" motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L. FEBS Lett. 554:111-118.
7. Fumo, G., C. Akin, D. D. Metcalfe, and L. Neckers. 2004. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood 103:1078-1084.
8. Goldstein, R. E., G. Jimenez, O. Cook, D. Gur, and Z. Paroush. 1999. Huckebein repressor activity in Drosophila terminal patterning is mediated by Groucho. Development 126:3747-3755.
9. Gommerman, J. L., and S. A. Berger. 1998. Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx. Blood 91:1891-1900.
10. Grandis, J. R., S. D. Drenning, Q. Zeng, S. C. Watkins, M. F. Melhem, S. Endo, D. E. Johnson, L. Huang, Y. He, and J. D. Kim. 2000. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. USA 97:4227-4232.
11. Gross, M., B. Liu, J. Tan, F. S. French, M. Carey, and K. Shuai. 2001. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20:3880-3887.
12. Gyotoku, E., E. Morita, Y. Kameyoshi, T. Hiragun, S. Yamamoto, and M. Hide. 2001. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice. Arch. Dermatol. Res. 293:508-514.
13. Hallsson, J. H., J. Favor, C. Hodgkinson, T. Glaser, M. L. Lamoreux, R. Magnusdottir, G. J. Gunnarsson, H. O. Sweet, N. G. Copeland, N. A. Jenkins, and E. Steingrimsson. 2000. Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics 155:291-300.
14. Hemesath, T. J., E. R. Price, C. Takemoto, T. Badalian, and D. E. Fisher. 1998. MAP kinase links the transcription factor microphthalmia to c-Kit signaling in melanocytes. Nature 391:298-301.
15. Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. Int. Rev. Immun. 16:249-284.
16. Hirano, T., K. Ishihara, and M. Hibi. 2000. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548-2556.
17. Hodgkinson, C. A., K. J. Moore, A. Nakayama, E. Steingrimsson, N. G. Copeland, N. A. Jenkins, and H. Arnheiter. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395-404.
18. Hoeffler, W. K., A. D. Levinson, and E. A. Bauer. 1994. Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain. Nucleic Acids Res. 22:1305-1312.
19. Hughes, M. J., L. J.B., J. M. Krakowsky, and K. P. Anderson. 1993. A helix-loop-helix transcription factor-like gene is located at the mi locus. J. Biol. Chem. 268:20687-20690.
20. Isozaki, K., T. Tsujimura, S. Nomura, E. Morii, U. Koshimizu, Y. Nishimune, and Y. Kitamura. 1994. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype. Am. J. Pathol. 145:827-836.
21. Ito, A., E. Morii, D. K. Kim, T. R. Kataoka, T. Jippo, K. Maeyama, H. Nojima, and Y. Kitamura. 1999. Inhibitory effect of the transcription factor encoded by the mi mutant allele in cultured mast cells of mice. Blood 93:1189-1196.
22. Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053-3058.
23. Jippo, T., E. Morii, A. Ito, and Y. Kitamura. 2003. Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice. J. Exp. Med. 197:1417-1425.
24. Kamaraju, A. K., C. Bertolotto, J. Chebath, and M. Revel. 2002. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling. J. Biol. Chem. 277:15132-15141.
25. Kaptein, A., V. Paillard, and M. Saunders. 1996. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271:5961-5964.
26. Kitamura, Y., E. Morii, T. Jippo, and A. Ito. 2002. Effect of MITF on mast cell differentiation. Mol. Immunol. 38:1173-1176.
27. Levy, C., H. Nechushtan, and E. Razin. 2002. A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277:1962-1966.
28. Levy, C., A. Sonnenblick, and E. Razin. 2003. The role played by MITF phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. Mol. Cell. Biol. 23:9073-9080.
29. Linnekin, D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 31:1053-1074.
30. Liu, B., M. Gross, J. ten Hoeve, and K. Shuai. 2001. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc. Natl. Acad. Sci. USA 98:3203-3207.
31. McGill, G. G., M. Horstmann, H. R. Widlund, J. Du, G. Motyckova, E. K. Nishimura, Y. L. Lin, S. Ramaswamy, W. Avery, H. F. Ding, S. A. Jordan, I. J. Jackson, S. J. Korsmeyer, T. R. Golub, and D. E. Fisher. 2002. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109:707-718.
32. Moore, K. J. 1995. Insight into the microphthalmia gene. Trends Genet. 11:442-450.
33. Morii, E., T. Jippo, K. Hashimoto, D.-K. Kim, Y.-M. Lee, H. Ogihara, K. Tsujino, H.-M. Kim, and Y. Kitamura. 1997. Abnormal expression of mouse mast cell protease 5 gene in cultured mast cells derived from mutant mi/mi mice. Blood 90:3057-3066.
34. Morii, E., H. Ogihara, K. Oboki, T. R. Kataoka, K. Maeyama, D. E. Fisher, M. L. Lamoreux, and Y. Kitamura. 2001. Effect of a large deletion of the basic domain of mi transcription factor on differentiation of mast cells. Blood 98:2577-2579.
35. Morii, E., T. Tsujimura, T. Jippo, K. Hashimoto, K. Takebayashi, K. Tsujino, S. Nomura, M. Yamamoto, and Y. Kitamura. 1996. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood 88:2488-2494.
36. Razin, E., C. Cardon-Cardo, and R. A. Good. 1981. Growth of a pure population of mouse mast cells in vitro using conditioned medium derived from Con A-stimulated splenocytes. Proc. Natl. Acad. Sci. USA 78:2559-2561.
37. Razin, E., Z. C. Zhang, H. Nechushtan, S. Frenkel, Y. N. Lee, R. Arudchandran, and J. Rivera. 1999. Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J. Biol. Chem. 274:34272-34276.
38. Rodel, B., K. Tavassoli, H. Karsunky, T. Schmidt, M. Bachmann, F. Schaper, P. Heinrich, K. Shuai, H. P. Elsasser, and T. Moroy. 2000. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J. 19:5845-5855.
39. Sinibaldi, D., W. Wharton, J. Turkson, T. Bowman, W. J. Pledger, and R. Jove. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419-5427.
40. Tachibana, M., K. Takeda, Y. Nobukuni, K. Urabe, J. E. Long, K. A. Meyers, S. A. Aaronson, and T. Miki. 1996. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat. Genet. 14:50-54.
41. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94:3801-3804.
42. Takeda, K., C. Takemoto, I. Kobayashi, A. Watanabe, Y. Nobukuni, D. E. Fisher, and M. Tachibana. 2000. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum. Mol. Genet. 9:125-132.
43. Weilbaecher, K. N., C. L. Hershey, C. M. Takemoto, M. A. Horstmann, T. J. Hemesath, A. H. Tashjian, and D. E. Fisher. 1998. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J. Exp. Med. 187:775-785.
44. mi/mi mice. Mol. Cell 8:749-758.
45. Wittekind, M., J. Reizer, J. Deutscher, M. H. Saier, and R. E. Klevit. 1989. Common structural changes accompany the functional inactivation of HPr by seryl phosphorylation or by serine to aspartate substitution. Biochemistry 28:9908-9912.
46. Wu, M., T. J. Hemesath, C. M. Takemoto, M. A. Horstmann, A. G. Wells, E. R. Price, D. Z. Fisher, and D. E. Fisher. 2000. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14:301-312.
47. Yanagida, M., H. Fukamachi, K. Ohgami, T. Kuwaki, H. Ishii, H. Uzumaki, K. Amano, T. Tokiwa, H. Mitsui, H. Saito, et al. 1995. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705-3714.